Insider Insights
10.02.2022
Reimbursement rate of gliptins revised downwards

In line with legislation published in the Official Journal (Journal Officiel) on 1st February 2022, ...

Read more
Insider Insights
09.02.2022
CMA fines firms 35 million

The actions of the companies meant that from December 2013 to December 2017, the price paid by the N...

Read more
Insider Insights
07.02.2022
NHS England announces access deal for Libmeldy

The news comes after the health service negotiated a “significant confidential discount” to the ...

Read more
Insider Insights
01.02.2022
UK NICE recommends selective laser therapy

According to updated guidelines published by NICE, patients newly diagnosed with glaucoma and ocular...

Read more
Insider Insights
01.02.2022
New restrictions for Prolia

The study showed that 20 - 25% of all prescriptions for the drug were not in line with the drug's au...

Read more
Insider Insights
01.02.2022
Self-care market growth

According to the association, the growth in the market was expected and can be explained by two fact...

Read more
Insider Insights
01.02.2022
Increasing prescribing controls on new medicines

According to data from the Ministry of Health 65.1% of medicines admitted to reimbursement in 2021 w...

Read more
Insider Insights
01.02.2022
GPS and specialists prescribe more diabetes

The Italian Medicines Agency has announced that General Practitioners will be able to prescribe mo...

Read more
Insider Insights
01.02.2022
Committee recommends rejecting Rx to non-Rx reques

The committee’s recommendations are forwarded to the Federal Ministry of Health for consideration.

Read more
Insider Insights
01.02.2022
Voluntary payment percentage set at 15

All other aspects of the voluntary scheme remain unchanged.

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.